Novartis raises drug sales forecast, plans new stock buybacks
Bio Pharma Dive
JULY 18, 2023
The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.
Bio Pharma Dive
JULY 18, 2023
The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.
Creogenic Pharma
APRIL 15, 2023
India is a major player in the global pharmaceutical industry, accounting for almost 20% of the export volume of generic drugs worldwide. Please contact us at sales@creogenicpharma.com or call at +918264379214 SEND ENQUIRY [contact-form-7] The post Pharma companies in Baddi appeared first on Creogenic Pharma.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JUNE 22, 2022
PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Then there is the cost of generic drugs. billion in 2020 if it had purchased 77 of 89 drugs from Cuban’s firm.
World of DTC Marketing
APRIL 12, 2021
Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages. Most of these generics are produced outside the US and recently there have been numerous recalls of generic drugs because of the failure of quality control.
World of DTC Marketing
DECEMBER 18, 2020
Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.
World of DTC Marketing
JULY 27, 2022
Huge Insurance companies continue shifting costs onto patients, with disastrous consequences for individuals’ health and society. Pharma companies have very little control over patients’ prices for their Rxs. Insurers have started coming after the co-pay coupons that many drug companies issue directly to patients.
Pharmaceutical Technology
FEBRUARY 24, 2023
EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies. But the EU draft document says that the changes will make medicines more affordable, improve unequal access to medicines across the EU, and fulfil unmet patient needs.
Let's personalize your content